| 340.09 Delayed Data As of Mar 04 |  +2.17 / +0.64%Today’s Change | 207.48 Today|||52-Week Range 341.93 | +12.11% Year-to-Date |
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.
| 1 month | +6.29% | 3 years | +41.58% | |
| 3 months | +9.67% | 5 years | +31.26% | |
| 1 year | +28.51% | Since inception | +9.20% |
| Previous close | $337.92 |
| Open day’s range | 334.00 – 341.93 |
| Net asset value (NAV) | 338.08 (03/03/2015) |
| Daily volume | 1,307,880 |
| Average volume (3 months) | 1,483,457 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +31.26% | +22.29% |
| Expense Gross exp ratio | 0.48% | 0.47% |
| Risk 5 year sharpe ratio | 1.62 | 1.51 |
| Net assets | $7.9B | $1.7B |
| Average market cap | $17.7B | $35.3B |
| Average P/E | 34.2 | 26.2 |
| Dividend / Share | -- | 0.21% |
| XLV Health Care Select Sector SPDR® Fund |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| BIIB Biogen | 9.72% |
| CELG Celgene | 7.81% |
| GILD Gilead Sciences | 7.54% |
| AMGN Amgen | 6.97% |
| REGN Regeneron Pharmaceuticals | 6.06% |
| ILMN Illumina Inc | 3.74% |
| VRTX Vertex Pharmaceuticals Inc | 3.70% |
| ALXN Alexion Pharmaceuticals Inc | 3.38% |
| -- | 3.37% |
| PCYC Pharmacyclics Inc | 2.56% |
